Interleukin-1 Receptor Antagonist [EPC]

16900 reported adverse events

Drugs of this class: ANAKINRA

These side effects are most commonly reported by patients taking drugs of the Interleukin-1 Receptor Antagonist [EPC] class:

# Side effect Count
0 OFF LABEL USE 5297
1 DRUG INEFFECTIVE 4355
2 CONDITION AGGRAVATED 1743
3 PAIN 1603
4 RHEUMATOID ARTHRITIS 1556
5 ARTHRALGIA 1207
6 JOINT SWELLING 1192
7 PYREXIA 1189
8 DRUG INTOLERANCE 1168
9 INJECTION SITE PAIN 1047
See all common reactions for Interleukin-1 Receptor Antagonist [EPC]

Drugs of the Interleukin-1 Receptor Antagonist [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HUMAN ANTICHIMERIC ANTIBODY POSITIVE 302 0.8988
1 BODY HEIGHT BELOW NORMAL 312 0.4852
2 AUTOINFLAMMATORY DISEASE 58 0.2736
3 ANKLE ARTHROPLASTY 96 0.2645
4 SHORT STATURE 59 0.2252
5 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 423 0.1834
6 JOINT DESTRUCTION 256 0.1645
7 JUVENILE IDIOPATHIC ARTHRITIS 372 0.1520
8 ANTIBODY TEST POSITIVE 235 0.1415
9 INTERLEUKIN LEVEL INCREASED 76 0.1377
See all enriched reactions for Interleukin-1 Receptor Antagonist [EPC]